Ei, A Pharmaceutical SolutionWorks, has signed agreements with European-based professors and technologists for the exclusive worldwide license of a novel class of sphingolipids. Sphingolipids are thought to play a critical role in strengthening the barrier function of the skin, promoting moisture retention and increasing elasticity of the skin. Ei has been granted options on several related technologies in various stages of development.   In preliminary clinical studies, the technology demonstra...